Weigensberg Arye 4

What Happened

• Arye Weigensberg, Senior Vice President and Head of Research & Development at Cronos Group Inc. (CRON), had two derivative-related transactions on March 8–9, 2026. On March 8 he exercised/converted 21,484 derivative units into common shares at $0.00 per share (record shows both an acquired and a corresponding derivative disposition entry at $0). On March 9 he was granted 63,919 restricted stock units (RSUs) with no purchase price recorded (value shown as $0 in the filing). RSUs vest in three substantially equal annual installments starting on the first anniversary of the grant.

Key Details

• Transaction dates and prices:
  • 2026-03-08: Exercise/conversion (code M) — 21,484 shares @ $0.00 (acquired) and a simultaneous derivative disposition entry @ $0.00.
  • 2026-03-09: Grant/award (code A) — 63,919 RSUs @ $0.00.
• Footnotes:
  • F1: Each RSU represents a contingent right to receive one common share.
  • F2: Prior grant (Mar 8, 2024) of 64,453 RSUs vests in three equal annual installments.
  • F3: The 63,919 RSU grant vests in three equal annual installments beginning on the first anniversary of the grant.
• Shares owned after the transaction: Not specified in this Form 4 filing.
• Filing timeliness: Reported on Mar 10, 2026 for transactions on Mar 8–9, 2026 — appears timely under the standard two-business-day reporting rule.
• Transaction codes: M = exercise/conversion of derivative; A = award/grant.

Context

• These entries reflect an internal conversion of derivative units and a new RSU grant (compensation/award), not an open-market purchase or sale. The $0.00 per-share amounts reflect that RSUs/converted units carry no out-of-pocket purchase price in the filing; market value is not shown here. Such grants and conversions are routine components of executive compensation and do not by themselves indicate the insider’s buy/sell sentiment.